Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2005 1
2006 1
2007 3
2009 2
2012 1
2013 4
2014 5
2015 1
2016 3
2017 8
2018 2
2019 4
2020 5
2021 7
2022 8
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Long-lasting severe immune dysfunction in Ebola virus disease survivors.
Wiedemann A, Foucat E, Hocini H, Lefebvre C, Hejblum BP, Durand M, Krüger M, Keita AK, Ayouba A, Mély S, Fernandez JC, Touré A, Fourati S, Lévy-Marchal C, Raoul H, Delaporte E, Koivogui L, Thiébaut R, Lacabaratz C, Lévy Y; PostEboGui Study Group. Wiedemann A, et al. Among authors: lacabaratz c. Nat Commun. 2020 Jul 24;11(1):3730. doi: 10.1038/s41467-020-17489-7. Nat Commun. 2020. PMID: 32709840 Free PMC article.
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J; French COVID Cohort Study Group; Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y. Coléon S, et al. Among authors: lacabaratz c. EBioMedicine. 2022 Jun;80:104062. doi: 10.1016/j.ebiom.2022.104062. Epub 2022 May 17. EBioMedicine. 2022. PMID: 35594660 Free PMC article.
Targeting human langerin promotes HIV-1 specific humoral immune responses.
Kervevan J, Bouteau A, Lanza JS, Hammoudi A, Zurawski S, Surenaud M, Dieudonné L, Bonnet M, Lefebvre C, Hocini H, Marlin R, Guguin A, Hersant B, Hermeziu O, Menu E, Lacabaratz C, Lelièvre JD, Zurawski G, Godot V, Henri S, Igyártó BZ, Levy Y, Cardinaud S. Kervevan J, et al. Among authors: lacabaratz c. PLoS Pathog. 2021 Jul 29;17(7):e1009749. doi: 10.1371/journal.ppat.1009749. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34324611 Free PMC article.
Durable natural killer cell responses after heterologous two-dose Ebola vaccination.
Wagstaffe HR, Susannini G, Thiébaut R, Richert L, Lévy Y, Bockstal V, Stoop JN, Luhn K, Douoguih M, Riley EM, Lacabaratz C, Goodier MR. Wagstaffe HR, et al. Among authors: lacabaratz c. NPJ Vaccines. 2021 Jan 29;6(1):19. doi: 10.1038/s41541-021-00280-0. NPJ Vaccines. 2021. PMID: 33514756 Free PMC article.
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.
Alexandre M, Marlin R, Prague M, Coleon S, Kahlaoui N, Cardinaud S, Naninck T, Delache B, Surenaud M, Galhaut M, Dereuddre-Bosquet N, Cavarelli M, Maisonnasse P, Centlivre M, Lacabaratz C, Wiedemann A, Zurawski S, Zurawski G, Schwartz O, Sanders RW, Le Grand R, Levy Y, Thiébaut R. Alexandre M, et al. Among authors: lacabaratz c. Elife. 2022 Jul 8;11:e75427. doi: 10.7554/eLife.75427. Elife. 2022. PMID: 35801637 Free PMC article.
Prevention of Ebola virus disease through vaccination: where we are in 2018.
Lévy Y, Lane C, Piot P, Beavogui AH, Kieh M, Leigh B, Doumbia S, D'Ortenzio E, Lévy-Marchal C, Pierson J, Watson-Jones D, Nguyen VK, Larson H, Lysander J, Lacabaratz C, Thiebaut R, Augier A, Ishola D, Kennedy S, Chêne G, Greenwood B, Neaton J, Yazdanpanah Y. Lévy Y, et al. Among authors: lacabaratz c. Lancet. 2018 Sep 1;392(10149):787-790. doi: 10.1016/S0140-6736(18)31710-0. Epub 2018 Aug 10. Lancet. 2018. PMID: 30104048 Free PMC article. No abstract available.
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination.
Surenaud M, Montes M, Lindestam Arlehamn CS, Sette A, Banchereau J, Palucka K, Lelièvre JD, Lacabaratz C, Lévy Y. Surenaud M, et al. Among authors: lacabaratz c. PLoS Pathog. 2019 Sep 9;15(9):e1008011. doi: 10.1371/journal.ppat.1008011. eCollection 2019 Sep. PLoS Pathog. 2019. PMID: 31498845 Free PMC article. Clinical Trial.
53 results